{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T03:36:51Z","timestamp":1778297811133,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.xphs.2016.08.028","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T00:47:36Z","timestamp":1477615656000},"page":"258-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Stability Orders of Acetaminophen and Theophylline Co-crystals Determined by Co-crystal Former Exchange Reactions and Their Correlation With  In Silico  and Thermal Parameters"],"prefix":"10.1016","volume":"106","author":[{"given":"Makoto","family":"Mukaida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruna","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohiko","family":"Sugano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhide","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.xphs.2016.08.028_bib1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/cg034035x","article-title":"Crystal engineering of the composition of pharmaceutical phases: multiple-component crystalline solids involving carbamazepine","volume":"3","author":"Fleischman","year":"2003","journal-title":"Cryst Growth Des"},{"issue":"28","key":"10.1016\/j.xphs.2016.08.028_bib2","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1021\/ja035776p","article-title":"Crystal engineering of novel cocrystals of a triazole drug with 1, 4-dicarboxylic acids","volume":"125","author":"Remenar","year":"2003","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.xphs.2016.08.028_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1039\/b208574g","article-title":"Crystal engineering of the composition of pharmaceutical phases","volume":"2","author":"Walsh","year":"2003","journal-title":"Chem Commun"},{"key":"10.1016\/j.xphs.2016.08.028_bib4","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1039\/b402150a","article-title":"Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?","volume":"17","author":"Almarsson","year":"2004","journal-title":"Chem Commun (Camb)"},{"issue":"3","key":"10.1016\/j.xphs.2016.08.028_bib5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jps.20578","article-title":"Pharmaceutical co-crystals","volume":"95","author":"Vishweshwar","year":"2006","journal-title":"J\u00a0Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2016.08.028_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.addr.2007.05.011","article-title":"Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates","volume":"59","author":"Blagden","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"issue":"9-10","key":"10.1016\/j.xphs.2016.08.028_bib7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.drudis.2008.03.004","article-title":"The role of cocrystals in pharmaceutical science","volume":"13","author":"Shan","year":"2008","journal-title":"Drug Discov Today"},{"issue":"6","key":"10.1016\/j.xphs.2016.08.028_bib8","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/cg900129f","article-title":"Pharmaceutical cocrystals and their physicochemical properties","volume":"9","author":"Schultheiss","year":"2009","journal-title":"Cryst Growth Des"},{"issue":"11","key":"10.1016\/j.xphs.2016.08.028_bib9","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.2042-7158.2010.01133.x","article-title":"Benefits of cocrystallisation in pharmaceutical materials science: an update","volume":"62","author":"Fri\u0161\u010di\u0107","year":"2010","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"1-2","key":"10.1016\/j.xphs.2016.08.028_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.07.037","article-title":"Pharmaceutical cocrystals: an overview","volume":"419","author":"Qiao","year":"2011","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2016.08.028_bib11","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1021\/cg801039j","article-title":"Solubility advantage of pharmaceutical cocrystals","volume":"9","author":"Good","year":"2009","journal-title":"Cryst Growth Des"},{"issue":"1","key":"10.1016\/j.xphs.2016.08.028_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2012.10.043","article-title":"Pharmaceutical cocrystals and poorly soluble drugs","volume":"453","author":"Thakuria","year":"2013","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2016.08.028_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1021\/cg800685z","article-title":"Can the formation of pharmaceutical cocrystals be computationally predicted? I. Comparison of lattice energies","volume":"9","author":"Issa","year":"2009","journal-title":"Cryst Growth Des"},{"issue":"5","key":"10.1016\/j.xphs.2016.08.028_bib14","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1021\/ct8004326","article-title":"Can the formation of pharmaceutical cocrystals be computationally predicted? 2. Crystal structure prediction","volume":"5","author":"Karamertzanis","year":"2009","journal-title":"J\u00a0Chem Theor Comput"},{"issue":"1-2","key":"10.1016\/j.xphs.2016.08.028_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpharm.2011.01.030","article-title":"Hansen solubility parameter as a tool to predict cocrystal formation","volume":"407","author":"Mohammad","year":"2011","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2016.08.028_bib16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1039\/c0sc00555j","article-title":"Virtual cocrystal screening","volume":"2","author":"Musumeci","year":"2011","journal-title":"Chem Sci"},{"issue":"4","key":"10.1016\/j.xphs.2016.08.028_bib17","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/cg401889h","article-title":"Virtual screening identifies new cocrystals of nalidixic acid","volume":"14","author":"Grecu","year":"2014","journal-title":"Cryst Growth Des"},{"issue":"1","key":"10.1016\/j.xphs.2016.08.028_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/cg401339v","article-title":"Validation of a computational cocrystal prediction tool: comparison of virtual and experimental cocrystal screening results","volume":"14","author":"Grecu","year":"2014","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2016.08.028_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cplett.2013.02.008","article-title":"Lattice energy calculation \u2013 a quick tool for screening of cocrystals and estimation of relative solubility. Case of flavonoids","volume":"564","author":"Kuleshova","year":"2013","journal-title":"Chem Phys Lett"},{"issue":"10","key":"10.1016\/j.xphs.2016.08.028_bib20","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1002\/jps.23227","article-title":"Rational coformer or solvent selection for pharmaceutical cocrystallization or desolvation","volume":"101","author":"Abramov","year":"2012","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2016.08.028_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1248\/cpb.c14-00480","article-title":"Stability order of caffeine co-crystals determined by co-crystal former exchange reaction and its application for the validation of in silico models","volume":"63","author":"Mukaida","year":"2015","journal-title":"Chem Pharm Bull"},{"issue":"9","key":"10.1016\/j.xphs.2016.08.028_bib22","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1002\/jps.22229","article-title":"A\u00a0red zwitterionic co-crystal of acetaminophen and 2,4-pyridinedicarboxylic acid","volume":"99","author":"Sander","year":"2010","journal-title":"J\u00a0Pharm Sci"},{"issue":"1-2","key":"10.1016\/j.xphs.2016.08.028_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2014.07.008","article-title":"Novel pharmaceutical cocrystal consisting of paracetamol and trimethylglycine, a new promising cocrystal former","volume":"473","author":"Maeno","year":"2014","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2016.08.028_bib24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1107\/S0108768102015987","article-title":"The formation of paracetamol (acetaminophen) adducts with hydrogen-bond acceptors","volume":"58","author":"Oswald","year":"2002","journal-title":"Acta Crystallogr B Struct Sci"},{"issue":"15","key":"10.1016\/j.xphs.2016.08.028_bib25","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1039\/c2ce25307k","article-title":"Revisiting paracetamol in a quest for new co-crystals","volume":"14","author":"Andr\u00e9","year":"2012","journal-title":"CrystEngComm"},{"issue":"38-39","key":"10.1016\/j.xphs.2016.08.028_bib26","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1002\/adma.200900533","article-title":"Improving mechanical properties of crystalline solids by cocrystal formation: new compressible forms of paracetamol","volume":"21","author":"Karki","year":"2009","journal-title":"Adv Mater"},{"issue":"1-2","key":"10.1016\/j.xphs.2016.08.028_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijpharm.2006.04.018","article-title":"Physical stability enhancement of theophylline via cocrystallization","volume":"320","author":"Trask","year":"2006","journal-title":"Int J Pharm"},{"issue":"14","key":"10.1016\/j.xphs.2016.08.028_bib28","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1039\/c2ce25299f","article-title":"The theophylline\u2013oxalic acid co-crystal system: solid phases, thermodynamics and crystallisation","volume":"14","author":"Zhang","year":"2012","journal-title":"CrystEngComm"},{"issue":"6","key":"10.1016\/j.xphs.2016.08.028_bib29","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1107\/S0021889811038970","article-title":"VESTA 3 for three-dimensional visualization of crystal, volumetric and morphology data","volume":"44","author":"Momma","year":"2011","journal-title":"J\u00a0Appl Crystallogr"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916416916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916416916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T22:32:30Z","timestamp":1530829950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916416916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0022354916416916"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2016.08.028","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stability Orders of Acetaminophen and Theophylline Co-crystals Determined by Co-crystal Former Exchange Reactions and Their Correlation With In Silico and Thermal Parameters","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2016.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}